Market revenue in 2023 | USD 21.0 million |
Market revenue in 2030 | USD 52.6 million |
Growth rate | 14.1% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 59.52% in 2023. Horizon Databook has segmented the South Korea microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea exhibits strong potential for R&D capabilities in the pharmaceutical and biopharmaceutical sectors, which is expected to boost the demand for sequencing products in research. Cancer research has become a national priority for the Korean government.
It supports several universities, institutions, and researchers to facilitate cancer research activities, which is anticipated to create a major demand for sequencing services in the coming years. Furthermore, increasing R&D investments by key pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth.
One of the leasing microbiome sequencing service providers in South Korea is Macrogen, Inc. The company provides customized solutions to analyze a person’s gut microbiome. Moreover, the company has been providing sequencing services to strengthen the capabilities of personalized medicine.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into South Korea microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account